Literature DB >> 15082225

Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice.

Michael Gruss1, Katharina Braun.   

Abstract

The Fragile X syndrome, a common form of mental retardation in humans, originates from the loss of expression of the Fragile X mental retardation gene leading to the absence of the encoded Fragile X mental retardation protein 1 (FMRP). A broad pattern of morphological and behavioral abnormalities is well described for affected humans as well as Fmr1 knock-out mice, a transgenic animal model for the human Fragile X syndrome. In the present study, we examined neurochemical differences between female Fmr1 knock-out and wildtype mice with particular focus on neurotransmission. Significant age- and region-specific differences of basal tissue neurotransmitter and metabolite levels measured by high performance liquid chromatography were found. Those differences were more numerous in juvenile animals (postnatal day (PND) 28-31) compared to adults (postnatal day 209-221). In juvenile female knock-out mice, especially aspartate and taurine were increased in cortical regions, striatum, cerebellum, and brainstem. Furthermore, compared to the wildtype animals, the juvenile knock-out mice displayed an increased level of neuronal inhibition in the hippocampus and brainstem reflected by decreased ratios of (aspartate + glutamate)/(taurine + GABA), as well as an increased dopamine (DA) turnover in cortical regions, striatum, and hippocampus. These results provide the first evidence that the lack of FMRP expression in female Fmr1 knock-out mice is accompanied by age-dependent, region-specific alterations in brain amino acids, and monoamine turnover, which might be related to the reported synaptical and behavioural alterations in these animals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082225     DOI: 10.1016/j.neuint.2003.12.001

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  15 in total

Review 1.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

Review 2.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

Review 3.  Revisiting the excitation/inhibition imbalance hypothesis of ASD through a clinical lens.

Authors:  Russell G Port; Lindsay M Oberman; Timothy Pl Roberts
Journal:  Br J Radiol       Date:  2019-06-11       Impact factor: 3.039

4.  Fronto-striatal dysfunction and potential compensatory mechanisms in male adolescents with fragile X syndrome.

Authors:  Fumiko Hoeft; Arvel Hernandez; Sudharshan Parthasarathy; Christa L Watson; Scott S Hall; Allan L Reiss
Journal:  Hum Brain Mapp       Date:  2007-06       Impact factor: 5.038

5.  Regulation of GABAA receptors by fragile X mental retardation protein.

Authors:  Baosong Liu; Lijun Li; Juan Chen; Zefen Wang; Zhiqiang Li; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

6.  Delineation of early attentional control difficulties in fragile X syndrome: focus on neurocomputational changes.

Authors:  Gaia Scerif; Kim Cornish; John Wilding; Jon Driver; Annette Karmiloff-Smith
Journal:  Neuropsychologia       Date:  2007-01-24       Impact factor: 3.139

7.  Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice.

Authors:  Da Shi; Su Xu; Jaylyn Waddell; Susanna Scafidi; Steven Roys; Rao P Gullapalli; Mary C McKenna
Journal:  J Neurochem       Date:  2012-11-07       Impact factor: 5.372

8.  Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging.

Authors:  Kanchan Singh; S Prasad
Journal:  Mol Biol Rep       Date:  2007-09-27       Impact factor: 2.316

9.  Behavioral and neurochemical alterations in mice lacking the RNA-binding protein translin.

Authors:  Joel M Stein; Wayland Bergman; Yanshan Fang; Lakesha Davison; Colleen Brensinger; Michael B Robinson; Norman B Hecht; Ted Abel
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

10.  Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.

Authors:  Rae R Matsumoto; Jamaluddin Shaikh; Lisa L Wilson; Shreedeepalakshmi Vedam; Andrew Coop
Journal:  Eur Neuropsychopharmacol       Date:  2008-08-27       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.